FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Venture group targets tech transfer deals in Texas

Emergent Technologies garnered $27.1 million in venture capital to license biotech research programs from the University of Texas. ETI has been operating in Texas for several years now. It specializes in identifying promising biotech research, licensing the technology and then spawning small start-up companies to advance the work. The company typically makes relatively small investments in each start-up and looks to larger pharma companies to come in and partner with them, providing much of the money necessary to grow the companies. Texas has lagged behind a large number of states that have seen their university research explode in recent years. The University of Florida system, meanwhile, has been one of the most active in the licensing arena.

- here's the report from the Austin American-Statesman

ALSO: A collaborative of scientists from South Florida and Latin America have begun seeking partners to advance their work in genomics. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Research Email Newsletter:
Be the first to comment

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.